Company: ECIA
Filing Date: 2025-07-14
Form Type: DEF 14A
Source: 0001079973-25-001145
Chunk: 14

Company: ENCISION INC
Filing Date: 2025-07-14
Form: DEF 14A
Chunk 14
---
 otherwise is not permitted to trade in Company securities. Our insider trading policy expressly prohibits derivative transactions of our stock by our executive officers and directors.

Encision has adoptedan insider trading policy that governs the purchase, sale, and other dispositions of the Company’s securities by directors, officers, and employees. The insider trading policy is designed to promote compliance with applicable securities laws and to prevent trading on the basis of material nonpublic information. A copy of the insider trading policy is available on the investor relations section of our corporate website at www.encision.com.

Rule 10b5-1 Sales Plans

Our policy governing transactions in our securities by directors, officers, and employees permits our officers, directors, and certain other persons to enter into trading plans complying with Rule 10b5-1 under the Exchange Act. Generally, under these trading plans, the individual relinquishes control over the transactions once the trading plan is put into place and can only put such plans into place while the individual is not in possession of material non-public information. Accordingly, sales under these plans may occur at any time, including possibly before, simultaneously with, or immediately after significant events involving our company. During FY 2025, none of our directors or executive officers had a Rule 10b5-1 in effect.

Equity Grant Timing

The Company does not determine the timing or terms of equity awards, including stock options or similar awards whose exercise price is related to the market value of our common stock, in connection with the release of material non-public information that is likely to result in changes to the price of our common stock, such as a significant positive or negative earnings announcement, and we do not timethe public release of such information based on stock option or other equity award grant dates.During fiscal year 2025, except as described in the table below, there were no equity awards granted to any of our named executive officers within either four business days before or one business day after the filing of our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, and any Current Report on Form 8-K that contained any material non-public information.

| Name              |     | Grant      
 Date       |     | Number                             
 of securities underlying the award |       |     | Exercise                 
 price of the award($/Sh) |     |     | Grant                    
 date fair value of award |       |     | Percent                                                                                                                               
 Change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the     
 disclosure